ReviewSeminars in immunopathology2016
The continuing evolution of targeted therapy for inflammatory skin disease.
C Schlapbach et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewSeminars in immunopathology2016
C Schlapbach et al.PubMed ↗Publisher ↗
No numbers read from the abstract.